Skip to main content

Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application

Active, not recruiting · NCT05094089

Conditions: Hernia, Ventral, Hernia Incisional, Hernia Incisional Ventral

At a glance

Research payments reported, 2025
$146,184
U.S. investigators named
8
Sites paid
8
Planned or actual enrollment
320

About the trial

Sponsor
W.L.Gore & Associates
Tested
Hernia repair with mesh (device)
Dates
Started 2023-02-24; completion 2030-07-31
Results posted
Not yet

The SYN 20-01 Study is a non-interventional, prospective, multicenter, multicohort, international, post-market clinical investigation looking into the assessment of GORE® SYNECOR Biomaterial in focused patient populations and in long-term application. Patients with ventral / incisional hernia amenable to hernia mesh repair will be enrolled into two cohorts (US and EU cohort) and followed-up over the period of 60 months.

From ClinicalTrials.gov, last updated 2026-11-05. Full record, eligibility and contacts (opens in a new tab)

Industry funding

W. L. Gore & Associates, Inc. reported $146,184 in research payments for this study in 2025 (24 payments).

Products named: Gore Synecor Preperitoneal Biomaterial, Gore Synecor Biomaterial

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.